|
Wednesday 9th August 2017 |
Text too small? |
Blis Technologies chief financial officer Tim Mepham has stepped down as the probiotics maker edges closer to turning a profit.
The Dunedin-based company said Mepham will leave "in the coming months to pursue other business interests" and it is searching for a full-time replacement. Mepham has been performing the role four days a week, it said.
Last month, Blis said it expects to post a maiden profit in the current financial year. The company, which was set up to commercialise probiotic bacteria for use in consumer products for oral health, colds and flu, reported a net loss of $24,000 in the 12 months ended March 31, narrowing from a loss of $816,000 a year earlier.
Blis had forecast a profit for the 2017 financial year but warned the market in February that pre-tax profit wasn't going to meet the $700,000 forecast due to significant reductions in purchases by three major customers.
The stock last traded at 3.5 cents and has shed 13 percent this year.
(BusinessDesk)
No comments yet
Fonterra announces Mainland Group leadership change
OCA - Oceania announces Director changes as part of Board refresh
AIA - Analyst and media webcast for FY26 interim results
The Warehouse Group confirms leaner operating structure
SML - Synlait provides half year performance update
RYM - Refreshed strategy and new capital management framework
ENS - Clarification of Gina Tuzcet’s status
BGP - 4th Quarter Sales to 25 January 2026
Contact Energy 2026 Half Year Results Presentation
February 2nd Morning Report